152 related articles for article (PubMed ID: 3018182)
1. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants.
Osterlind K; Hansen HH; Hansen M; Dombernowsky P; Andersen PK
J Clin Oncol; 1986 Sep; 4(9):1307-13. PubMed ID: 3018182
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.
Osterlind K; Andersen PK
Cancer Res; 1986 Aug; 46(8):4189-94. PubMed ID: 3015384
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
Lassen U; Osterlind K; Hansen M; Dombernowsky P; Bergman B; Hansen HH
J Clin Oncol; 1995 May; 13(5):1215-20. PubMed ID: 7738624
[TBL] [Abstract][Full Text] [Related]
4. Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer.
Osterlind K; Hansen HH; Hansen M; Dombernowsky P
J Clin Oncol; 1986 Jul; 4(7):1044-52. PubMed ID: 3014082
[TBL] [Abstract][Full Text] [Related]
5. Influence of age on the treatment of limited-stage small-cell lung cancer.
Siu LL; Shepherd FA; Murray N; Feld R; Pater J; Zee B
J Clin Oncol; 1996 Mar; 14(3):821-8. PubMed ID: 8622030
[TBL] [Abstract][Full Text] [Related]
6. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA
Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and prognostic staging system for small cell lung cancer.
Kawahara M; Fukuoka M; Saijo N; Nishiwaki Y; Ikegami H; Tamura T; Shimoyama M; Suemasu K; Furuse K
Jpn J Clin Oncol; 1997 Jun; 27(3):158-65. PubMed ID: 9255270
[TBL] [Abstract][Full Text] [Related]
8. Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994.
Lebitasy MP; Hédelin G; Purohit A; Moreau L; Klinzig F; Quoix E
Br J Cancer; 2001 Sep; 85(6):808-15. PubMed ID: 11556829
[TBL] [Abstract][Full Text] [Related]
9. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
[TBL] [Abstract][Full Text] [Related]
10. Practical approaches to the treatment of patients with extensive stage small cell lung cancer.
Greco FA; Hainsworth JD
Semin Oncol; 1994 Aug; 21(4 Suppl 7):3-6. PubMed ID: 7522349
[TBL] [Abstract][Full Text] [Related]
11. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
[TBL] [Abstract][Full Text] [Related]
12. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
Ihde DC; Deisseroth AB; Lichter AS; Bunn PA; Carney DN; Cohen MH; Veach SR; Makuch RW; Johnston-Early A; Abrams RA
J Clin Oncol; 1986 Oct; 4(10):1443-54. PubMed ID: 3020181
[TBL] [Abstract][Full Text] [Related]
13. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW
Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701
[TBL] [Abstract][Full Text] [Related]
14. Determinants of complete remission induction and maintenance in chemotherapy with or without irradiation of small cell lung cancer.
Osterlind K; Hansen HH; Dombernowsky P; Hansen M; Andersen PK
Cancer Res; 1987 May; 47(10):2733-6. PubMed ID: 3032413
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
[TBL] [Abstract][Full Text] [Related]
16. Combined modality therapy including surgery for stage III small-cell lung cancer on the basis of the sensitivity assay in vitro.
Kobayashi S; Okada S; Hasumi T; Sato N; Fujimura S
Surg Today; 2000; 30(2):127-33. PubMed ID: 10664334
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.
Spiegelman D; Maurer LH; Ware JH; Perry MC; Chahinian AP; Comis R; Eaton W; Zimmer B; Green M
J Clin Oncol; 1989 Mar; 7(3):344-54. PubMed ID: 2537384
[TBL] [Abstract][Full Text] [Related]
18. Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.
Arriagada R; Kramar A; Le Chevalier T; De Cremoux H
J Clin Oncol; 1992 Mar; 10(3):447-51. PubMed ID: 1311025
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors and therapeutic strategies in small cell bronchial carcinoma].
Thiele KP
Praxis (Bern 1994); 1997 Oct; 86(42):1660-7. PubMed ID: 9432688
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
